(29 days)
Not Found
No
The summary describes a mechanical device for fluid administration with a safety feature, and there is no mention of AI or ML.
Yes
The device is used for the intravenous administration of fluids, which is a therapeutic procedure.
No
The device is described as an administration set for the intravenous administration of fluids, and is not indicated for the diagnosis of any condition.
No
The device description clearly describes a physical administration set with a safety shield, indicating it is a hardware device, not software only.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "intravenous administration of fluids." This is a therapeutic or procedural use, not a diagnostic one.
- Device Description: The description focuses on the mechanism for infusing fluids and preventing needlesticks, which are related to the administration of substances into the body, not the testing of samples from the body.
- Lack of IVD Characteristics: The text does not mention any of the typical characteristics of an IVD, such as:
- Analyzing samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in samples
- Providing information for diagnosis, monitoring, or screening
The device is clearly intended for direct use on a patient for the purpose of administering fluids, which falls outside the scope of in vitro diagnostics.
N/A
Intended Use / Indications for Use
The BD Vacutainer® Safety-Lok™ Administration Set with Filter is a sterile, single-use winged set intended for the intravenous administration of fluids and may be used for any patient population with consideration given to patient size, appropriateness for the solution being infused and duration of therapy. The BD Vacutainer® Safety-Lok™ Administration Set with Filter minimizes the possibility of needlesticks if manually activated following administration.
Product codes
FPA
Device Description
The BD Vacutainer® Safety-Lok™ Administration Set with Filter is intended for the infusion of fluids. The wing set contains a safety shield that is manually activated once infusion is complete, helping to prevent accidental needle sticks.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
any patient population
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Extensive mechanical and compatibility testing was performed to demonstrate the device's safety and effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
NOV 1 8 2003
Attachment 4
510(k) Summary Of Safety and Effectiveness
- I. General Information
This Summary of Safety and Effectiveness information is being submitted in accordance with the requirements of the SMDA of 1990 and 21 § 807.92
Establishment:
.
| • Address: | BD Diagnostics, Preanalytical Systems
1 Becton Drive
Franklin Lakes, NJ 07417-1885 |
|------------------------|------------------------------------------------------------------------------------------|
| • Registration Number: | 2243072 |
| • Contact Person: | M. Wendy Ballesteros
Regulatory Affairs Specialist |
Date of Summary: ● Device
Trade Name:
October 17, 2003
Fax No. 201-847-4858
BD Vacutainer® Safety-Lok™ Administration Set with Filter
- Classification Name: ●
- Classification:
- Performance Standards: ●
Intravascular Administration Set
Telephone no.: 201-847-6280
Class II None Established under 514 of the Food, Drug and Cosmetic Act
1
- II. Safety and Effectiveness Information Supporting Substantial Equivalence
- · Device Description
The BD Vacutainer® Safety-Lok™ Administration Set with Filter is intended for the infusion of fluids. The wing set contains a safety shield that is manually activated once infusion is complete, helping to prevent accidental needle sticks.
-
· Intended Use
The BD Vacutainer® Safety-Lok™ Administration Set with Filter is a sterile, single-use winged set intended for the intravenous administration of fluids and may be used for any patient population with consideration given to patient size, appropriateness for the solution being infused and duration of therapy. The BD Vacutainer® Safety-Lok™ Administration Set with Filter minimizes the possibility of needlesticks if manually activated following administration. -
· Synopsis of Performance Study Results
Extensive mechanical and compatibility testing was performed to demonstrate the device's safety and effectiveness.
III. Predicate Device Summary Table
- · Substantial Equivalence
Based on comparison of the device features, materials, intended use and performance, the BD Vacutainer® Safety-Lok™ Administration Set with Filter is shown to be substantially equivalent to the commercially available predicate device indicated in the table below. The predicate device, K number, and clearance date are also identified in the table below.
| Manufacturer | Predicate Device | K-Number | Clearance Date |
|---|---|---|---|
| Becton | |||
| Dickinson | BD Vacutainer® | ||
| Safety-Lok™ Blood | |||
| Collection Set | K980414 | March 3, 1998 |
u Ballisterf
Oct. 17, 2003
Date
M. Wendv Ballesteros Regulatory Affairs Specialist BD Diagnostics, PreAnalytical Systems Pecton Dickinson and Company
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the circle is a stylized symbol that resembles an eagle or a bird in flight, composed of three curved lines.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 1 8 2003
Becton Dickinson Company M. Wendy Ballesteros Regulatory Affairs Specialist BD Diagnostics, Preanalytical Systems 1 Becton Drive Franklin lakes, New Jersey 07417
Re: K033350
Trade/Device Name: BD Vacutainer® Safety-Lok™ Administration Set with Filter Regulation Number: 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: FPA Dated: October 17, 2003 Received: October 24, 2003
Dear Ms. Ballesteros:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Ballesteros
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Chuls
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Attachment 2
B. INDICATIONS FOR USE
510(K) Number (IF Known):
DEVICE NAME: BD Vacutainer® Safety-Lok™ Administration Set with Filter
INDICATIONS FOR USE:
The BD Vacutainer® Safety-Lok™ Administration Set with Filter is a sterile, single-use wing set intended for the intravenous administration of fluids and may be used for any patic population with consideration given to patient size, appropriateness for the solution being infus and duration of therapy. The BD Vacutainer® Safety-Lok™ Administration Set with Fil minimizes the possibility of needlesticks if manually activated following administration.
(Please do not Write Below this line-continue on another Page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
PRESCRIPTION USE
سسا
OR Over-The-Counter Use
(Per 21 CFR § 801.109)
(OPTIONAL FORMAT 1-2-S
Patricia Cucenté
ision Sign-Off) on of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: K033350